In this report, the United States Escitalopram market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Escitalopram in these regions, from 2013 to 2025 (forecast).
United States Escitalopram market competition by top manufacturers/players, with Escitalopram sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Forest Laboratories(US)
H.Lundbeck A/S(DK)
Amneal Pharmaceuticals(US)
Aurobindo Pharma(IN)
Hetero Drugs(IN)
Macleods Pharmaceuticals(IN)
Silarx Pharmacueticals(US)
Apotex(CA)
Hikma Pharmaceuticals(UK)
Jubilant Pharma(SG)
Lupin Limited(IN)
Prinston Pharmaceutical(US)
STI Pharma(US)
TEVA Pharmaceutical(US)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Solution
Tablet
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals and Clinics
Individual Use
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Escitalopram Market Report 2018
1 Escitalopram Overview
1.1 Product Overview and Scope of Escitalopram
1.2 Classification of Escitalopram by Product Category
1.2.1 United States Escitalopram Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Escitalopram Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Solution
1.2.4 Tablet
1.2.5 Others
1.3 United States Escitalopram Market by Application/End Users
1.3.1 United States Escitalopram Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals and Clinics
1.3.3 Individual Use
1.3.4 Others
1.4 United States Escitalopram Market by Region
1.4.1 United States Escitalopram Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Escitalopram Status and Prospect (2013-2025)
1.4.3 Southwest Escitalopram Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Escitalopram Status and Prospect (2013-2025)
1.4.5 New England Escitalopram Status and Prospect (2013-2025)
1.4.6 The South Escitalopram Status and Prospect (2013-2025)
1.4.7 The Midwest Escitalopram Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Escitalopram (2013-2025)
1.5.1 United States Escitalopram Sales and Growth Rate (2013-2025)
1.5.2 United States Escitalopram Revenue and Growth Rate (2013-2025)
2 United States Escitalopram Market Competition by Players/Suppliers
2.1 United States Escitalopram Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Escitalopram Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Escitalopram Average Price by Players/Suppliers (2013-2018)
2.4 United States Escitalopram Market Competitive Situation and Trends
2.4.1 United States Escitalopram Market Concentration Rate
2.4.2 United States Escitalopram Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Escitalopram Manufacturing Base Distribution, Sales Area, Product Type
3 United States Escitalopram Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Escitalopram Sales and Market Share by Region (2013-2018)
3.2 United States Escitalopram Revenue and Market Share by Region (2013-2018)
3.3 United States Escitalopram Price by Region (2013-2018)
4 United States Escitalopram Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Escitalopram Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Escitalopram Revenue and Market Share by Type (2013-2018)
4.3 United States Escitalopram Price by Type (2013-2018)
4.4 United States Escitalopram Sales Growth Rate by Type (2013-2018)
5 United States Escitalopram Sales (Volume) by Application (2013-2018)
5.1 United States Escitalopram Sales and Market Share by Application (2013-2018)
5.2 United States Escitalopram Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Escitalopram Players/Suppliers Profiles and Sales Data
6.1 Forest Laboratories(US)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Escitalopram Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Forest Laboratories(US) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 H.Lundbeck A/S(DK)
6.2.2 Escitalopram Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 H.Lundbeck A/S(DK) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Amneal Pharmaceuticals(US)
6.3.2 Escitalopram Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Amneal Pharmaceuticals(US) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Aurobindo Pharma(IN)
6.4.2 Escitalopram Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Aurobindo Pharma(IN) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Hetero Drugs(IN)
6.5.2 Escitalopram Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Hetero Drugs(IN) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Macleods Pharmaceuticals(IN)
6.6.2 Escitalopram Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Macleods Pharmaceuticals(IN) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Silarx Pharmacueticals(US)
6.7.2 Escitalopram Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Silarx Pharmacueticals(US) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Apotex(CA)
6.8.2 Escitalopram Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Apotex(CA) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Hikma Pharmaceuticals(UK)
6.9.2 Escitalopram Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Hikma Pharmaceuticals(UK) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Jubilant Pharma(SG)
6.10.2 Escitalopram Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Jubilant Pharma(SG) Escitalopram Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Lupin Limited(IN)
6.12 Prinston Pharmaceutical(US)
6.13 STI Pharma(US)
6.14 TEVA Pharmaceutical(US)
7 Escitalopram Manufacturing Cost Analysis
7.1 Escitalopram Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Escitalopram
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Escitalopram Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Escitalopram Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Escitalopram Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Escitalopram Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Escitalopram Sales Volume Forecast by Type (2018-2025)
11.3 United States Escitalopram Sales Volume Forecast by Application (2018-2025)
11.4 United States Escitalopram Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Escitalopram
Figure United States Escitalopram Market Size (K Units) by Type (2013-2025)
Figure United States Escitalopram Sales Volume Market Share by Type (Product Category) in 2017
Figure Solution Product Picture
Figure Tablet Product Picture
Figure Others Product Picture
Figure United States Escitalopram Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Escitalopram by Application in 2017
Figure Hospitals and Clinics Examples
Table Key Downstream Customer in Hospitals and Clinics
Figure Individual Use Examples
Table Key Downstream Customer in Individual Use
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Escitalopram Market Size (Million USD) by Region (2013-2025)
Figure The West Escitalopram Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Escitalopram Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Escitalopram Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Escitalopram Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Escitalopram Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Escitalopram Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Escitalopram Sales (K Units) and Growth Rate (2013-2025)
Figure United States Escitalopram Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Escitalopram Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Escitalopram Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Escitalopram Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Escitalopram Sales Share by Players/Suppliers
Figure 2017 United States Escitalopram Sales Share by Players/Suppliers
Figure United States Escitalopram Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Escitalopram Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Escitalopram Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Escitalopram Revenue Share by Players/Suppliers
Figure 2017 United States Escitalopram Revenue Share by Players/Suppliers
Table United States Market Escitalopram Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Escitalopram Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Escitalopram Market Share of Top 3 Players/Suppliers
Figure United States Escitalopram Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Escitalopram Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Escitalopram Product Category
Table United States Escitalopram Sales (K Units) by Region (2013-2018)
Table United States Escitalopram Sales Share by Region (2013-2018)
Figure United States Escitalopram Sales Share by Region (2013-2018)
Figure United States Escitalopram Sales Market Share by Region in 2017
Table United States Escitalopram Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Escitalopram Revenue Share by Region (2013-2018)
Figure United States Escitalopram Revenue Market Share by Region (2013-2018)
Figure United States Escitalopram Revenue Market Share by Region in 2017
Table United States Escitalopram Price (USD/Unit) by Region (2013-2018)
Table United States Escitalopram Sales (K Units) by Type (2013-2018)
Table United States Escitalopram Sales Share by Type (2013-2018)
Figure United States Escitalopram Sales Share by Type (2013-2018)
Figure United States Escitalopram Sales Market Share by Type in 2017
Table United States Escitalopram Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Escitalopram Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Escitalopram by Type (2013-2018)
Figure Revenue Market Share of Escitalopram by Type in 2017
Table United States Escitalopram Price (USD/Unit) by Types (2013-2018)
Figure United States Escitalopram Sales Growth Rate by Type (2013-2018)
Table United States Escitalopram Sales (K Units) by Application (2013-2018)
Table United States Escitalopram Sales Market Share by Application (2013-2018)
Figure United States Escitalopram Sales Market Share by Application (2013-2018)
Figure United States Escitalopram Sales Market Share by Application in 2017
Table United States Escitalopram Sales Growth Rate by Application (2013-2018)
Figure United States Escitalopram Sales Growth Rate by Application (2013-2018)
Table Forest Laboratories(US) Basic Information List
Table Forest Laboratories(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Forest Laboratories(US) Escitalopram Sales Growth Rate (2013-2018)
Figure Forest Laboratories(US) Escitalopram Sales Market Share in United States (2013-2018)
Figure Forest Laboratories(US) Escitalopram Revenue Market Share in United States (2013-2018)
Table H.Lundbeck A/S(DK) Basic Information List
Table H.Lundbeck A/S(DK) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure H.Lundbeck A/S(DK) Escitalopram Sales Growth Rate (2013-2018)
Figure H.Lundbeck A/S(DK) Escitalopram Sales Market Share in United States (2013-2018)
Figure H.Lundbeck A/S(DK) Escitalopram Revenue Market Share in United States (2013-2018)
Table Amneal Pharmaceuticals(US) Basic Information List
Table Amneal Pharmaceuticals(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amneal Pharmaceuticals(US) Escitalopram Sales Growth Rate (2013-2018)
Figure Amneal Pharmaceuticals(US) Escitalopram Sales Market Share in United States (2013-2018)
Figure Amneal Pharmaceuticals(US) Escitalopram Revenue Market Share in United States (2013-2018)
Table Aurobindo Pharma(IN) Basic Information List
Table Aurobindo Pharma(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aurobindo Pharma(IN) Escitalopram Sales Growth Rate (2013-2018)
Figure Aurobindo Pharma(IN) Escitalopram Sales Market Share in United States (2013-2018)
Figure Aurobindo Pharma(IN) Escitalopram Revenue Market Share in United States (2013-2018)
Table Hetero Drugs(IN) Basic Information List
Table Hetero Drugs(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hetero Drugs(IN) Escitalopram Sales Growth Rate (2013-2018)
Figure Hetero Drugs(IN) Escitalopram Sales Market Share in United States (2013-2018)
Figure Hetero Drugs(IN) Escitalopram Revenue Market Share in United States (2013-2018)
Table Macleods Pharmaceuticals(IN) Basic Information List
Table Macleods Pharmaceuticals(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Macleods Pharmaceuticals(IN) Escitalopram Sales Growth Rate (2013-2018)
Figure Macleods Pharmaceuticals(IN) Escitalopram Sales Market Share in United States (2013-2018)
Figure Macleods Pharmaceuticals(IN) Escitalopram Revenue Market Share in United States (2013-2018)
Table Silarx Pharmacueticals(US) Basic Information List
Table Silarx Pharmacueticals(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Silarx Pharmacueticals(US) Escitalopram Sales Growth Rate (2013-2018)
Figure Silarx Pharmacueticals(US) Escitalopram Sales Market Share in United States (2013-2018)
Figure Silarx Pharmacueticals(US) Escitalopram Revenue Market Share in United States (2013-2018)
Table Apotex(CA) Basic Information List
Table Apotex(CA) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Apotex(CA) Escitalopram Sales Growth Rate (2013-2018)
Figure Apotex(CA) Escitalopram Sales Market Share in United States (2013-2018)
Figure Apotex(CA) Escitalopram Revenue Market Share in United States (2013-2018)
Table Hikma Pharmaceuticals(UK) Basic Information List
Table Hikma Pharmaceuticals(UK) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hikma Pharmaceuticals(UK) Escitalopram Sales Growth Rate (2013-2018)
Figure Hikma Pharmaceuticals(UK) Escitalopram Sales Market Share in United States (2013-2018)
Figure Hikma Pharmaceuticals(UK) Escitalopram Revenue Market Share in United States (2013-2018)
Table Jubilant Pharma(SG) Basic Information List
Table Jubilant Pharma(SG) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Jubilant Pharma(SG) Escitalopram Sales Growth Rate (2013-2018)
Figure Jubilant Pharma(SG) Escitalopram Sales Market Share in United States (2013-2018)
Figure Jubilant Pharma(SG) Escitalopram Revenue Market Share in United States (2013-2018)
Table Lupin Limited(IN) Basic Information List
Table Prinston Pharmaceutical(US) Basic Information List
Table STI Pharma(US) Basic Information List
Table TEVA Pharmaceutical(US) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Escitalopram
Figure Manufacturing Process Analysis of Escitalopram
Figure Escitalopram Industrial Chain Analysis
Table Raw Materials Sources of Escitalopram Major Players/Suppliers in 2017
Table Major Buyers of Escitalopram
Table Distributors/Traders List
Figure United States Escitalopram Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Escitalopram Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Escitalopram Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Escitalopram Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Escitalopram Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Escitalopram Sales Volume (K Units) Forecast by Type in 2025
Table United States Escitalopram Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Escitalopram Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Escitalopram Sales Volume (K Units) Forecast by Application in 2025
Table United States Escitalopram Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Escitalopram Sales Volume Share Forecast by Region (2018-2025)
Figure United States Escitalopram Sales Volume Share Forecast by Region (2018-2025)
Figure United States Escitalopram Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
